跳至主要内容
临床试验/JPRN-UMIN000016601
JPRN-UMIN000016601已完成未知

A randomized controlled study to examine the effects of a triple therapy with vonoprazan or rabeprazole against standard triple therapy-failed patients. - A triple therapy with vonoprazan or rabeprazole against standard triple therapy-failed patients

Juntendo University School of Medicine, Department of Gstroenterology0 个研究点目标入组 70 人开始时间: 2015年2月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who cannot cancel a proton pump inhibitor for 2 weeks before judgment after re-eradication therapy. 2. Patients who have past history of drug allergy. 3. Patients who have severe diseases affecting the kidney, the heart, and the liver. 4. Patients who are pregnant, who may be pregnant, or who are nursing.

研究者

发起方
Juntendo University School of Medicine, Department of Gstroenterology

相似试验